Stock 688202 SHANGHAI MEDICILON INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Shanghai Medicilon Inc.

Equities

688202

CNE100003NQ8

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
26.05 CNY -2.32% Intraday chart for Shanghai Medicilon Inc. -8.76% -61.90%
13/05 Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023. CI
12/05 Shanghai Medicilon Inc.'s Equity Buyback announced on November 13, 2023, has closed with 745,166 shares, representing 0.55% for CNY 39.98 million. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.
CI
Shanghai Medicilon Inc.'s Equity Buyback announced on November 13, 2023, has closed with 745,166 shares, representing 0.55% for CNY 39.98 million.
CI
Shanghai Medicilon Inc. announces an Equity Buyback for CNY 20 million worth of its shares.
CI
Shanghai Medicilon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shanghai Medicilon Inc. authorizes a Buyback Plan.
CI
Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.
CI
China Healthcare Stocks Rally on Hopes for Government Support
DJ
Medicilon Appoints Dr. Qingcong Lin as President of Medicilon Usa Corp
CI
Shanghai Medicilon Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Medicilon Appoints Dr. Zhang Haizhou as President of Preclinical R&D Unit
CI
Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.
CI
Shanghai Medicilon Inc.(SHSE:688202) dropped from Shanghai Stock Exchange Health Care Sector Index
CI
Shanghai Medicilon Inc. announces an Equity Buyback for CNY 40 million worth of its shares.
CI
Shanghai Medicilon Inc. authorizes a Buyback Plan.
CI
Shanghai Medicilon Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Medicilon Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Fosun Health Capital Reaches Cooperation Agreement with Medicilon to Explore Innovative Drug Research and Development Together
CI
Five times in a row, Medicilon was shortlisted in the '2022 China CXO Enterprises Top 20 List'
AQ
Medicilon topped the 'Top 10 Most Influential CRO Enterprises' in the 2023 China Biopharmaceutical Industry Value List
AQ
Shanghai Medicilon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688202 Stock
  4. News Shanghai Medicilon Inc.